- Home
- Publications
- Publication Search
- Publication Details
Title
Medical treatment of neuroendocrine tumours
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume 20, Issue 1, Pages 27-31
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-08-30
DOI
10.1097/med.0b013e32835c034f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy
- (2012) M. Dong et al. CLINICAL CANCER RESEARCH
- TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
- (2012) G. Rindi et al. JNCI-Journal of the National Cancer Institute
- Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
- (2012) Roeland F de Wilde et al. MODERN PATHOLOGY
- ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update
- (2012) Ramon Salazar et al. NEUROENDOCRINOLOGY
- Inhibition of mTOR in carcinoid tumors
- (2012) Simona Grozinsky-Glasberg et al. Targeted Oncology
- Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
- (2011) Eric Raymond et al. CANCER AND METASTASIS REVIEWS
- Overcoming Antiangiogenic Resistance: Figure 1.
- (2011) James C. Yao et al. CLINICAL CANCER RESEARCH
- New Treatment Options for Patients with Advanced Neuroendocrine Tumors
- (2011) Jennifer A. Chan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
- (2011) Günter Klöppel ENDOCRINE-RELATED CANCER
- mTOR inhibitor therapy for patients with carcinoid
- (2011) Guido Rindi et al. LANCET
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Promising Advances in the Treatment of Malignant Pancreatic Endocrine Tumors
- (2011) Robert T. Jensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers
- (2011) Marco Volante et al. VIRCHOWS ARCHIV
- Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
- (2010) David S. Klimstra et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas
- (2010) Nicola Fazio et al. CANCER TREATMENT REVIEWS
- The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
- (2010) J. Philip Boudreaux et al. PANCREAS
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement
- (2010) Günter Klöppel et al. VIRCHOWS ARCHIV
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
- (2008) David C. Metz et al. GASTROENTEROLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started